ACN vs ADMA · P/E 24, rev $17.60B vs P/E 22, rev $238.9M
Accenture plc (ACN) versus ADMA Biologics Inc (ADMA) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
ADMA Biologics Inc (ADMA) is a biotechnology company listed on US.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported ADMA revenue for 2026-06-30 was $238.9M. Net income was $83.2M. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. ADMA currently screens at market cap $4.39B and trailing P/E 21.9.
Not investment advice. Open the ACN and ADMA stock pages for the full models.
Not investment advice.